0

506919

MAKERSL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

MAKERS LABORATORIES LTD. Share Price Today

Investment Returns

Over 1 Month -8.67% Over 3 Months -3.06% Over 6 Months 26.43% Over 1 Year -2.45%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MAKERS LABORATORIES LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 86.90
  • P/E Ratio (TTM) -50.62
  • Beta 0.99
  • Book Value / share 92.24
  • Return on equity -9.63%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -0.96
info icon alternate text

MAKERS LABORATORIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 11.27
Operating Expense 12.45
Net Profit -0.96
Net Profit Margin (%) -8.51
Earnings Per Share (EPS) -1.63
EBITDA -0.35
Effective Tax Rate (%) 17.24
Particulars DEC 2025 (Values in Cr)
Revenue 12.70
Operating Expense 12.85
Net Profit -0.17
Net Profit Margin (%) -1.33
Earnings Per Share (EPS) -0.29
EBITDA 0.72
Effective Tax Rate (%) -21.42
Particulars SEP 2025 (Values in Cr)
Revenue 12.64
Operating Expense 13.57
Net Profit -0.31
Net Profit Margin (%) -2.45
Earnings Per Share (EPS) -0.53
EBITDA 0.44
Effective Tax Rate (%) 24.39
Particulars JUN 2025 (Values in Cr)
Revenue 13.73
Operating Expense 14.06
Net Profit -0.27
Net Profit Margin (%) -1.96
Earnings Per Share (EPS) -0.46
EBITDA 0.50
Effective Tax Rate (%) 10.00
Particulars MAR 2025 (Values in Cr)
Revenue 9.70
Operating Expense 11.69
Net Profit -1.40
Net Profit Margin (%) -14.43
Earnings Per Share (EPS) -2.38
EBITDA -1.19
Effective Tax Rate (%) 28.93
Particulars MAR 2026 (Values in Cr)
Revenue 50.35
Operating Expense 52.95
Net Profit -1.72
Net Profit Margin (%) -3.41
Earnings Per Share (EPS) -2.91
EBITDA 1.32
Effective Tax Rate (%) 14.42
Particulars MAR 2025 (Values in Cr)
Revenue 42.94
Operating Expense 48.94
Net Profit 4.64
Net Profit Margin (%) 10.80
Earnings Per Share (EPS) 7.87
EBITDA 8.71
Effective Tax Rate (%) 5.88
Particulars MAR 2024 (Values in Cr)
Revenue 49.09
Operating Expense 57.19
Net Profit -6.95
Net Profit Margin (%) -14.15
Earnings Per Share (EPS) -11.78
EBITDA -2.62
Effective Tax Rate (%) 0.14
Particulars MAR 2023 (Values in Cr)
Revenue 42.55
Operating Expense 50.46
Net Profit -6.36
Net Profit Margin (%) -14.94
Earnings Per Share (EPS) -10.58
EBITDA -3.00
Effective Tax Rate (%) 6.04
Particulars MAR 2022 (Values in Cr)
Revenue 52.38
Operating Expense 52.92
Net Profit 0.17
Net Profit Margin (%) 0.32
Earnings Per Share (EPS) 0.35
EBITDA 3.90
Effective Tax Rate (%) 45.16
Particulars MAR 2025 (Values in Cr)
Book Value / Share 119.49
ROE % 4.90
ROCE % 6.43
Total Debt to Total Equity 0.22
EBITDA Margin 8.36
Particulars MAR 2024 (Values in Cr)
Book Value / Share 106.85
ROE % -7.27
ROCE % -2.19
Total Debt to Total Equity 0.29
EBITDA Margin 2.54
Particulars MAR 2023 (Values in Cr)
Book Value / Share 117.28
ROE % -3.40
ROCE % 1.60
Total Debt to Total Equity 0.31
EBITDA Margin 5.53
Particulars MAR 2022 (Values in Cr)
Book Value / Share 121.17
ROE % 20.61
ROCE % 22.06
Total Debt to Total Equity 0.38
EBITDA Margin 16.86
Particulars MAR 2021 (Values in Cr)
Book Value / Share 110.08
ROE % 2.49
ROCE % 5.96
Total Debt to Total Equity 0.38
EBITDA Margin 13.23
Particulars MAR 2025 (Values in Cr)
Book Value / Share 95.04
ROE % -9.63
ROCE % -6.71
Total Debt to Total Equity 0.16
EBITDA Margin -3.21
Particulars MAR 2024 (Values in Cr)
Book Value / Share 87.19
ROE % -12.67
ROCE % -7.69
Total Debt to Total Equity 0.24
EBITDA Margin -5.32
Particulars MAR 2023 (Values in Cr)
Book Value / Share 98.78
ROE % -11.71
ROCE % -7.67
Total Debt to Total Equity 0.28
EBITDA Margin -7.05
Particulars MAR 2022 (Values in Cr)
Book Value / Share 102.30
ROE % 0.42
ROCE % 3.01
Total Debt to Total Equity 0.35
EBITDA Margin 7.54
Particulars MAR 2021 (Values in Cr)
Book Value / Share 100.92
ROE % -3.44
ROCE % -0.78
Total Debt to Total Equity 0.31
EBITDA Margin 8.38
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.64
Total Assets 147.94
Total Liabilities 147.94
Total Equity 115.19
Share Outstanding 0
Price to Book Ratio 1.36
Return on Assets (%) 5.06
Return on Capital (%) 6.32
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.23
Total Assets 161.25
Total Liabilities 161.25
Total Equity 104.33
Share Outstanding 0
Price to Book Ratio 1.29
Return on Assets (%) -3.88
Return on Capital (%) -5.13
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 4.36
Total Assets 152.29
Total Liabilities 152.29
Total Equity 109.67
Share Outstanding 0
Price to Book Ratio 0.99
Return on Assets (%) -3.11
Return on Capital (%) -3.92
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.67
Total Assets 144.33
Total Liabilities 144.33
Total Equity 98.09
Share Outstanding 0
Price to Book Ratio 1.78
Return on Assets (%) 3.44
Return on Capital (%) 4.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.21
Total Assets 136.19
Total Liabilities 136.19
Total Equity 86.57
Share Outstanding 0
Price to Book Ratio 2.37
Return on Assets (%) -0.24
Return on Capital (%) -0.33
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 71.39
Total Liabilities 71.39
Total Equity 56.07
Share Outstanding 0
Price to Book Ratio 1.36
Return on Assets (%) 6.50
Return on Capital (%) 8.23
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.07
Total Assets 86.14
Total Liabilities 86.14
Total Equity 51.44
Share Outstanding 0
Price to Book Ratio 1.29
Return on Assets (%) -8.06
Return on Capital (%) -10.69
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.07
Total Assets 84.79
Total Liabilities 84.79
Total Equity 58.28
Share Outstanding 0
Price to Book Ratio 0.99
Return on Assets (%) -7.50
Return on Capital (%) -9.42
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 85.48
Total Liabilities 85.48
Total Equity 50.30
Share Outstanding 0
Price to Book Ratio 1.78
Return on Assets (%) 0.20
Return on Capital (%) 0.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.34
Total Assets 79.11
Total Liabilities 79.11
Total Equity 49.62
Share Outstanding 0
Price to Book Ratio 2.37
Return on Assets (%) -2.04
Return on Capital (%) -2.55
Particulars MAR 2025 (Values in Cr)
Net Income 13.41
Cash from Operations -1.67
Cash from Investing 19.74
Cash from Financing -15.83
Net change in Cash -0.17
Free Cash Flow 2.26
Particulars MAR 2024 (Values in Cr)
Net Income -3.91
Cash from Operations 2.61
Cash from Investing -6.88
Cash from Financing 5.73
Net change in Cash -0.30
Free Cash Flow 9.23
Particulars MAR 2023 (Values in Cr)
Net Income -0.83
Cash from Operations -6.15
Cash from Investing 1.25
Cash from Financing 5.78
Net change in Cash -1.58
Free Cash Flow 6.75
Particulars MAR 2022 (Values in Cr)
Net Income 15.68
Cash from Operations 24.13
Cash from Investing -21.79
Cash from Financing 0.32
Net change in Cash -2.96
Free Cash Flow 34.01
Particulars MAR 2025 (Values in Cr)
Net Income 4.92
Cash from Operations -1.14
Cash from Investing 16.13
Cash from Financing -14.55
Net change in Cash 0.00
Free Cash Flow 1.27
Particulars MAR 2024 (Values in Cr)
Net Income -6.95
Cash from Operations -2.74
Cash from Investing -2.03
Cash from Financing 5.11
Net change in Cash 0.01
Free Cash Flow -0.04
Particulars MAR 2023 (Values in Cr)
Net Income -6.77
Cash from Operations -1.02
Cash from Investing -3.55
Cash from Financing 4.93
Net change in Cash -0.03
Free Cash Flow 3.45
Particulars MAR 2022 (Values in Cr)
Net Income 0.31
Cash from Operations 7.35
Cash from Investing -8.78
Cash from Financing 1.76
Net change in Cash -0.20
Free Cash Flow 18.44
Particulars MAR 2021 (Values in Cr)
Net Income -2.07
Cash from Operations 2.04
Cash from Investing -2.64
Cash from Financing 1.37
Net change in Cash -0.61
Free Cash Flow 3.48
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.51 13.02 1.52 241.47 23.12 38.85
BLISS GVS PHARMA LTD 492.50 39.98 4.37 5223.27 118.35 495.00
CIPLA LTD. 1440.30 30.57 3.37 116353.96 1165.55 1672.20
FERMENTA BIOTECH LTD. 365.50 16.12 2.64 1075.70 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.51 22.03 4.05 241.47 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 538.05 24.12 4.20 1555.54 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8382.65 109.48 24.01 20956.63 7630.00 9850.00
BLISS GVS PHARMA LTD 492.50 53.13 4.52 5223.27 118.35 495.00

MAKERS LABORATORIES LTD. shareholding pattern

Holding
38.33%
61.27%
0.38%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

MAKERS LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
147.30 0.95 redarrow
red-green-graph indicator
12 Bearish
4 Bullish
  • 5 Days 146.80
  • 26 Days 150.60
  • 10 Days 147.70
  • 50 Days 151.10
  • 12 Days 148.20
  • 100 Days 147.80
  • 20 Days 149.80
  • 200 Days 144.60
145.55 PIVOT
First Support 143.35 First Resistance 148.10 Second Support 140.80 Second Resistance 150.30 Third Support 138.60 Third Resistance 152.85
RSI 46.44 ADX 24.48 MACD -2.43 Williams % R -55.40 Commodity Channel Index (CCI) -46.06
Date 2026-06-25 Week 2993.00 Same Day 1170.00 Month 5290.00
1 Year 0.99 3 Year 0.53
Over 1 Month
-8.67% down
Over 1 Year
-2.45% down
Over 3 Months
-3.06% down
Over 3 Years
10.30% down
Over 6 Months
26.43% down
Over 5 Years
-4.15% down

MAKERS LABORATORIES LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
01 Aug 2019 1.0 Final 03 Aug 2019 Equity shares
26 Jul 2018 1.0 Final 28 Jul 2018 Equity shares
20 Jul 2017 1.0 Final 22 Jul 2017 Equity shares
02 Aug 2016 1.0 Final 04 Aug 2016 Equity shares
28 Jul 2015 1.0 Final 30 Jul 2015 Equity shares
29 Jul 2011 1.0 Final 02 Aug 2011 Equity shares
17 Aug 2010 1.0 Final 19 Aug 2010 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Makers Laboratories Ltd?

Answer Field

Makers Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 147.30 as on Jun 25 2026 03:29 PM.

What is the Market Cap of Makers Laboratories Ltd Share?

Answer Field

The market cap of Makers Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 86.90 as on Jun 25 2026 03:29 PM.

What is the 52 Week High and Low of Makers Laboratories Ltd?

Answer Field

The 52 Week High and Low of Makers Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 186.70 and ₹ 109.00.

What is 1 year return for Makers Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -2.45%.

What is the P/E Ratio of Makers Laboratories Ltd Share?

Answer Field

As on Jun 25 2026 03:29 PM the price-to-earnings (PE) ratio for Makers Laboratories Ltd share is -50.62.

What is the PB ratio of Makers Laboratories Ltd Share?

Answer Field

As on Jun 25 2026 03:29 PM, the price-to-book (PB) ratio for Makers Laboratories Ltd share is 92.24.

How to Buy Makers Laboratories Ltd Share?

Answer Field

You can trade in Makers Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Makers Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Makers Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Makers Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|